CTRI/2020/08/027146
Recruiting
未知
A randomised controlled trial to study the early preterm delivery in pregnant women between supplemented with 200 mg/day and 1000 mg/day of DHA from second trimester. - DHA
Cloudnine Hospital0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Cloudnine Hospital
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pregnant females of 18\- 40 years of age
- •Gestational age 12\-20 weeks
- •\- Singleton pregnancy, irrespective of co morbidities
- •\- Dietary intake of DHA is \<200 mg/day
- •\- Available by telephone, to verify dietary compliance
- •\- South Asian population
Exclusion Criteria
- •\- Women with allergy to any component of DHA product (including algae), soybean oil or corn oil
- •\- Uterine anomalies
- •\- Women with fetal anomalies at 20 weeks or early, which may require termination of pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Pilot study for a randomized controlled trial of preventing locomotive syndrome through exercise at local pharmaciesJPRN-UMIN000027963agoya City University Graduate School of Pharmaceutical Sciences12
Active, not recruiting
Not Applicable
Early Positive Approaches to Support (E-PAtS) for families of young children with intellectual disability: a randomised controlled trialIntellectual disabilityMental and Behavioural DisordersISRCTN11192967niversity of Kent594
Active, not recruiting
Not Applicable
A clinical trial to compare the outcomes between two different liver grafts in recipients and donors after live donor liver transplantatioHealth Condition 1: null- To study the early post operative outcomes in patients who undergoe live donor liver transplantation as per standard accepted criteria.Outcome in donors who undergoe the donor surgery is also studiedCTRI/2016/08/007186Christi Titus Varghese61
Completed
Phase 1
A randomised, controlled phase 1 study to investigate the safety and efficacy of orally administered squalamine in subjects with Motor Neuron DiseaseMotor Neuron DiseaseNeurological - Neurodegenerative diseasesACTRN12619000375156Wesley Medical Research12
Completed
Not Applicable
Pilot study of a randomised controlled trial of antenatal thromboprophylaxisPregnancy and childbirth: thromboembolic disease (TED)Pregnancy and ChildbirthThromboembolic disease (TED)ISRCTN21644138HS R&D Regional Programme Register - Department of Health (UK)16